| Literature DB >> 30090524 |
Anna A Krasilnikova1,2, Anastasiya O Solovieva1,2, Anton A Ivanov1,3, Konstantin A Brylev3,4, Tatiana N Pozmogova2,4, Marina A Gulyaeva1,4, Olga G Kurskaya1, Alexander Y Alekseev1, Alexander M Shestopalov1, Lidiya V Shestopalova4, Alexander F Poveshchenko2, Olga A Efremova5, Yuri V Mironov3,4, Michael A Shestopalov1,2,3,4.
Abstract
The octahedral rhenium cluster compound Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] has recently emerged as a very promising X-ray contrast agent for biomedical applications. However, the synthesis of this compound is rather challenging due to the difficulty in controlling the hydrolysis of the initial P(C2H4CN)3 ligand during the reaction process. Therefore, in this report we compare the in vitro and in vivo toxicity of Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] with those of related compounds featuring the fully hydrolysed form of the phosphine ligand, namely Na2H14[{Re6Q8}(P(C2H4COO)3)6] (Q = S or Se). Our results demonstrate that the cytotoxicity and acute in vivo toxicity of the complex Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] solutions were considerably lower than those of compounds with the fully hydrolysed ligand P(C2H4COOH)3. Such behavior can be explained by the higher osmolality of Na2H14[{Re6Q8}(P(C2H4COO)3)6] versus Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6].Entities:
Year: 2017 PMID: 30090524 PMCID: PMC6060950 DOI: 10.1039/c7tx00083a
Source DB: PubMed Journal: Toxicol Res (Camb) ISSN: 2045-452X Impact factor: 3.524
Fig. 1Cell viability response of HeLa, Hep-2 and MPh cells using the MTT assay for (1), (2) and (3).
The IC50 of (1), (2) and (3) on the Hep-2, HeLa cells and peritoneal macrophages determined by the MTT assay
| Compound | IC50 values, mM | ||
| MPh | HeLa | Hep-2 | |
| ( | 1.27 ± 0.03 | 1.42 ± 0.07 | 1.80 ± 0.64 |
| ( | 0.36 ± 0.06 | 0.82 ± 0.03 | 1.07 ± 0.08 |
| ( | 1.72 ± 0.58 | 1.66 ± 0.14 | 5.60 ± 0.17 |
Fig. 2Confocal fluorescence microscopy of peritoneal macrophages (A–F), HeLa (G–L) and Hep-2 (M–R) after incubation with (1), (2) and (3) for 24 hours. Red fluorescence and merged (phase contrast and fluorescence) images.
Fig. 3Survival rate of mice injected intravenously with 0.1 mL of the cluster complexes (1) or (2) at different doses (n = 10).
The osmolality of aqueous solutions of the cluster complexes (1), (2) and (3) at different concentrations
| Compound |
|
| Osmolality, mOsm kg–1 |
| ( | 70 | 62.7 | 580 ± 1 |
| 50 | 44.8 | 398 ± 2 | |
| 30 | 26.9 | 257 ± 4 | |
| 10 | 9.0 | 96 ± 1 | |
| ( | 70 | 62.7 | 613 ± 5 |
| 50 | 44.8 | 425 ± 2 | |
| 30 | 26.9 | 255 ± 1 | |
| 10 | 9.0 | 99 ± 1 | |
| ( | 70 | 62.7 | 279 ± 2 |
| 50 | 44.8 | 198 ± 1 | |
| 30 | 26.9 | 122 ± 1 | |
| 10 | 9.0 | 51 ± 1 |